Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Survival after radiation therapy for high-grade glioma.

Marra JS, Mendes GP, Yoshinari GH Jr, da Silva Guimarães F, Mazin SC, de Oliveira HF.

Rep Pract Oncol Radiother. 2019 Jan-Feb;24(1):35-40. doi: 10.1016/j.rpor.2018.09.003. Epub 2018 Oct 11.

PMID:
30337846
2.

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

Paravati AJ, Heron DE, Landsittel D, Flickinger JC, Mintz A, Chen YF, Huq MS.

J Neurooncol. 2011 Aug;104(1):339-49. doi: 10.1007/s11060-010-0499-8. Epub 2010 Dec 22.

3.
4.

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.

Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.

PMID:
16168843
5.

Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.

Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):892-7.

PMID:
16458777
6.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJ, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.

Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.

7.

Radiotherapy in supratentorial gliomas. A study of 821 cases.

Heesters M, Molenaar W, Go GK.

Strahlenther Onkol. 2003 Sep;179(9):606-14.

PMID:
14628126
8.

Surgery, radiotherapy and temozolomide in treating high-grade gliomas.

Parlato C, Barbarisi M, Moraci M, Moraci A.

Front Biosci. 2006 May 1;11:1280-3.

PMID:
16368514
9.

Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma.

Muni R, Minniti G, Lanzetta G, Caporello P, Frati A, Enrici MM, Marchetti P, Enrici RM.

Tumori. 2010 Jan-Feb;96(1):60-4.

PMID:
20437859
10.

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B.

Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38.

11.

Cervicomedullary tumors in children.

McAbee JH, Modica J, Thompson CJ, Broniscer A, Orr B, Choudhri AF, Boop FA, Klimo P Jr.

J Neurosurg Pediatr. 2015 Oct;16(4):357-66. doi: 10.3171/2015.5.PEDS14638. Epub 2015 Jun 26.

PMID:
26114990
12.

Radiotherapy of spinal cord gliomas : A retrospective mono-institutional analysis.

Corradini S, Hadi I, Hankel V, Ertl L, Ganswindt U, Belka C, Niyazi M.

Strahlenther Onkol. 2016 Mar;192(3):139-45. doi: 10.1007/s00066-015-0917-0. Epub 2015 Oct 30.

PMID:
26519080
13.

Temozolomide and radiotherapy as first-line treatment of high-grade gliomas.

Corsa P, Parisi S, Raguso A, Troiano M, Perrone A, Cossa S, Munafò T, Piombino M, Spagnoletti G, Borgia F.

Tumori. 2006 Jul-Aug;92(4):299-305.

PMID:
17036520
14.

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M.

Strahlenther Onkol. 2004 Jul;180(7):401-7. Review.

PMID:
15241527
15.

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.

Fujii Y, Muragaki Y, Maruyama T, Nitta M, Saito T, Ikuta S, Iseki H, Hongo K, Kawamata T.

J Neurosurg. 2018 Jul;129(1):1-9. doi: 10.3171/2017.3.JNS162383. Epub 2017 Sep 8.

PMID:
28885120
16.

Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.

Paulino AC, Mazloom A, Terashima K, Su J, Adesina AM, Okcu MF, Teh BS, Chintagumpala M.

Cancer. 2013 Jul 15;119(14):2654-9. doi: 10.1002/cncr.28118. Epub 2013 Apr 30.

17.

CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures.

Oermann E, Collins BT, Erickson KT, Yu X, Lei S, Suy S, Hanscom HN, Kim J, Park HU, Eldabh A, Kalhorn C, McGrail K, Subramaniam D, Jean WC, Collins SP.

J Hematol Oncol. 2010 Jun 9;3:22. doi: 10.1186/1756-8722-3-22.

18.

Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis.

Erpolat OP, Akmansu M, Goksel F, Bora H, Yaman E, Büyükberber S.

Tumori. 2009 Mar-Apr;95(2):191-7.

PMID:
19579865
19.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389
20.

Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.

Clavo B, Robaina F, Jorge IJ, Cabrera R, Ruiz-Egea E, Szolna A, Otermin E, Llontop P, Carames MA, Santana-Rodríguez N, Sminia P.

Integr Cancer Ther. 2014 Nov;13(6):513-9. doi: 10.1177/1534735414550037. Epub 2014 Sep 15.

PMID:
25228535

Supplemental Content

Support Center